AREB

American Rebel is a sub-$100K market-cap shell in acute financial distress, and the filing language confirms it. Revenue is not just small but shrinking — $9.52M in FY2025, down 16.6% YoY and down from the $16.0M FY2023 peak — while the company simultaneously fails to make money on the products it does sell: gross profit is NEGATIVE (-$198K, -2.1% gross margin). A business that loses money at the gross line before any overhead has no path to profitability by scaling; every incremental sale destroys value. Net loss ballooned to -$34.3M on that $9.52M of revenue (a -360% net margin), and the accumulated deficit sits at -$99.4M against just $4.38M of stockholders' equity.

The balance sheet is the disqualifier. Cash is down to $148K (-48.7% YoY) against $26.0M of current liabilities versus only $5.64M of current assets — a working-capital hole of roughly $20M and a current ratio near 0.22. Short-term borrowings exploded to $19.6M (+297%), liabilities/equity is 6.26x, and operating cash flow was -$7.22M. With $148K of cash and $7M+ annual cash burn, the company is wholly dependent on continuous, dilutive financing to survive. The share count tells that story in reverse: shares 'outstanding' of just 233K (down 77.3%) and a diluted EPS of -$63,214 are the fingerprints of massive reverse stock splits used to stay listed while issuing new stock — a textbook death spiral for existing holders.